Happify is making its app-based treatment available to patients thanks to a loosened FDA guidance last year that lets digital health companies targeting some behavioral health conditions release their product without clearance. The company is launching an investigational study to get data for a future FDA submission.
Cigna has been pushing heavily into digital health as evidenced by a venture capital arm it launched earlier this year as well as acquisitions like its 2017 purchase of digital practice management company Brighter.
Discover nine top caregiver services with flexible scheduling to fit changing routines, shift work or evolving health needs — featuring trusted platforms and in-home care providers.
This move will enable Happify to team with academic researchers to conduct clinical trials on interventions related to positive psychology and neuroscience.
Ambitions for Happify Health include addressing resilience, mindfulness, depression, anxiety, chronic pain and mood disorders on-demand.